ProfileGDS5678 / 1431954_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 54% 54% 54% 53% 54% 54% 58% 54% 53% 54% 54% 53% 59% 54% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3668954
GSM967853U87-EV human glioblastoma xenograft - Control 23.3474354
GSM967854U87-EV human glioblastoma xenograft - Control 33.3454654
GSM967855U87-EV human glioblastoma xenograft - Control 43.2421153
GSM967856U87-EV human glioblastoma xenograft - Control 53.2860254
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4471954
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5750258
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3411254
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2819553
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2999154
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.3329654
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2739353
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5335859
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.3414454